Iron Path Capital (IPC), an operationally focused private equity firm investing in the specialty industrials and healthcare sectors, announced the final closing of Iron Path Capital Fund I, exceeding the $250 million target with total commitments of $273 million.
The Fund I limited partners consist of a diverse group of global investors, including leading endowments, fund of funds, institutional investors, and family offices.
Iron Path Capital targets control investments in lower-middle market specialty industrial and healthcare companies in partnership with founders and managers for building and growing businesses. And Iron Path focuses on sectors where the firm has deep expertise and where they can create transformational outcomes with the operational resources of the Full Immersion Operations team (FIOps).
M2O Private Fund Advisors acted as the exclusive placement agent. Foley & Lardner served as fund counsel.
KEY QUOTES:
“We are extremely grateful for the investors that have decided to partner with us in our inaugural institutional fund. This marks an important achievement for the firm and is a reflection of our differentiated capabilities and the strong team that we have built over our first three years.”
- Iron Path Managing Partner and Co-founder Rob Reistetter
“Our approach includes developing an investment thesis and partnering with founders and managers to scale businesses organically and with strategic acquisitions. We have curated a team of limited partners, strategic advisors and Iron Path professionals who share our unique vision and our steadfast values.”
- Scott Mraz, fellow co-founder and Managing Partner
